Các bài nghiên cứu mới về COVID-19 từ ngày 15/10 đến ngày 22/10/2021

Cập nhật vào: Thứ năm - 21/10/2021 23:47 Cỡ chữ Nhỏ Lớn

Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 15/10 đến ngày 22/10/2021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

1. Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection

International Immunopharmacology, 27 July 2021, Volume 99, Article 108013

Flaminia Tomassetti, Marzia Nuccetelli, Sergio Bernardini

https://www.sciencedirect.com/science/article/pii/S1567576921006494/pdfft?md5=9a6b63ca478968d6e52a6ef967d7058c&pid=1-s2.0-S1567576921006494-main.pdf

2. SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors

European Journal of Internal Medicine, 18 May 2021, Volume 89, Pages 87-96

Evangelos Terpos, Dimitris Stellas, Meletios A. Dimopoulos

https://www.sciencedirect.com/science/article/pii/S0953620521001618/pdfft?md5=3bde7cdeb618d8f371d78fdc556e9e3c&pid=1-s2.0-S0953620521001618-main.pdf

3. The effect of aerobic exercise on immune biomarkers and symptoms severity and progression in patients with COVID-19: A randomized control trial

Journal of Bodywork and Movement Therapies, 5 August 2021, Volume 28, Pages 425-432

Ayman A. Mohamed, Motaz Alawna

https://www.sciencedirect.com/science/article/pii/S1360859221001674/pdfft?md5=0a6ec8516d4aa5eb925f6a6a33799235&pid=1-s2.0-S1360859221001674-main.pdf

4. Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan

Biochemistry and Biophysics Reports, 29 December 2020, Volume 25 (Cover date: March 2021), Article 100896

Walid Al-Zyoud, Hazem Haddad

https://www.sciencedirect.com/science/article/pii/S2405580820302065/pdfft?md5=eba83b32721b5fdda1cc8d8ff2d4b8de&pid=1-s2.0-S2405580820302065-main.pdf

5. Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques

Virology, 29 December 2020, Volume 554 (Cover date: February 2021), Pages 97-105

Hirohito Ishigaki, Misako Nakayama, Yasushi Itoh

https://www.sciencedirect.com/science/article/pii/S0042682220302609/pdfft?md5=8e0a82d66912147c2776730179f08d83&pid=1-s2.0-S0042682220302609-main.pdf

6. A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia

Vaccine, 24 September 2021, Volume 39, Issue 44, Pages 6520-6528

Eddy Fadlyana, Kusnandi Rusmil, Cissy B. Kartasasmita

https://www.sciencedirect.com/science/article/pii/S0264410X2101255X/pdfft?md5=e7f291e850ea3c249c4a7da6de2d15a6&pid=1-s2.0-S0264410X2101255X-main.pdf

7. COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use.

Endocrine and Metabolic Science, 8 August 2021, Volume 5, Article 100109

Shilpa Bhuaptrai Shah

https://www.sciencedirect.com/science/article/pii/S2666396121000327/pdfft?md5=30bea4a9618ecf4868274fc3a8900e71&pid=1-s2.0-S2666396121000327-main.pdf

8. Automatic Detection of Coronavirus Disease (COVID-19) in X-ray and CT Images: A Machine Learning Based Approach

Biocybernetics and Biomedical Engineering, 5 June 2021, Volume 41, Issue 3, Pages 867-879

Sara Hosseinzadeh Kassania, Peyman Hosseinzadeh Kassanib, Ralph Detersa

https://www.sciencedirect.com/science/article/pii/S020852162100067X/pdfft?md5=bbcefe821d73554e73b5af49001ffdc8&pid=1-s2.0-S020852162100067X-main.pdf

9. An extended fuzzy decision-making framework using hesitant fuzzy sets for the drug selection to treat the mild symptoms of Coronavirus Disease 2019 (COVID-19)

Applied Soft Computing, 5 February 2021, Volume 103, Article 107155

Arunodaya Raj Mishra, Pratibha Rani, Samarjit Kar

https://www.sciencedirect.com/science/article/pii/S1568494621000788/pdfft?md5=cd9bac480030a08bcf6dbb7c92715de2&pid=1-s2.0-S1568494621000788-main.pdf

10. High-throughput analysis of the interactions between viral proteins and host cell RNAs

Computers in Biology and Medicine, 2 July 2021, Volume 135, Article 104611

Hossein Lanjanian, Sajjad Nematzadeh, Ali Masoudi-Nejad

https://www.sciencedirect.com/science/article/pii/S0010482521004054/pdfft?md5=d82cc562c20d6134cfeaf36bef5c90ce&pid=1-s2.0-S0010482521004054-main.pdf

11. Screening of world approved drugs against highly dynamical spike glycoprotein of SARS-CoV-2 using CaverDock and machine learning

Computational and Structural Biotechnology Journal, 26 May 2021, Volume 19, Pages 3187-3197

Gaspar P. Pinto, Ondrej Vavra, Jiri Damborsky

https://www.sciencedirect.com/science/article/pii/S2001037021002245/pdfft?md5=fef924911db99077185d32bfe0dbf74a&pid=1-s2.0-S2001037021002245-main.pdf

12. Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An observation cohort study in China

International Journal of Infectious Diseases, 28 April 2021, Volume 107, Pages 242-246

Yangzi Song, Chen Chen, Fujie Zhang

https://www.sciencedirect.com/science/article/pii/S120197122100388X/pdfft?md5=a2e7e14a9e51eba57a234b2a926e1368&pid=1-s2.0-S120197122100388X-main.pdf

13. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil

Infection, Genetics and Evolution, 10 July 2021, Volume 94, Article 104998

Livia R. Goes, Juliana D. Siqueira, Marcelo A. Soares

https://www.sciencedirect.com/science/article/pii/S1567134821002951/pdfft?md5=15508ce44b2d833a51ab1a7cbb558333&pid=1-s2.0-S1567134821002951-main.pdf

14. Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals

Journal of Virological Methods, 24 December 2020, Volume 289 (Cover date: March 2021), Article 114060

E. Catry, H. Jacqmin, T. D. Huang

https://www.sciencedirect.com/science/article/pii/S0166093420303128/pdfft?md5=328cd3693eff0228b2a82fdfef1cbb0a&pid=1-s2.0-S0166093420303128-main.pdf

15. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance

EClinicalMedicine, 8 July 2021, Volume 38, Article 101027

Marco Montalti, Giorgia Soldà, Davide Gori

https://www.sciencedirect.com/science/article/pii/S2589537021003072/pdfft?md5=9fb2e1b60675f200d785f0a204900126&pid=1-s2.0-S2589537021003072-main.pdf

16. Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study

Medical Journal Armed Forces India, 26 July 2021, Volume 77, Pages s283-s288

Deep Kamal, Vaidehi Thakur, Rajesh Batlish

https://www.sciencedirect.com/science/article/pii/S037712372100160X/pdfft?md5=77dce44698ff3699a275879f0dbaa158&pid=1-s2.0-S037712372100160X-main.pdf

17. Adverse events occurring post-covid-19 vaccination among healthcare professionals – A mixed method study

International Immunopharmacology, 16 September 2021, Volume 100, Article 108136

Soumya Mahapatra, Ruchi Nagpal, Sakshi Kataria

https://www.sciencedirect.com/science/article/pii/S1567576921007724/pdfft?md5=9b1f3a9f320d2d107fc3faf012d1d3ee&pid=1-s2.0-S1567576921007724-main.pdf

18. Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study

Vaccine, 24 September 2021, Volume 39, Issue 44, Pages 6492-6509

Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Arvind Sharma

https://www.sciencedirect.com/science/article/pii/S0264410X21012585/pdfft?md5=ec6e4e0b359f35ba0846637b11146b9c&pid=1-s2.0-S0264410X21012585-main.pdf

19. Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis

Medical Hypotheses, 9 November 2020, Volume 146 (Cover date: January 2021), Article 110365

Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz, Ahmed Abdellatif

https://www.sciencedirect.com/science/article/pii/S0306987720332564/pdfft?md5=9cdb0a97b9df5933659503d5bf5d3c8f&pid=1-s2.0-S0306987720332564-main.pdf

20. Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients

EBioMedicine, 20 October 2021, Volume 73, Article 103626

Juan Manuel Carreño, Hala Alshammary, Viviana Simon

https://www.sciencedirect.com/science/article/pii/S2352396421004199/pdfft?md5=9e0c059ac44959f9bcc7cbd071e4a1cc&pid=1-s2.0-S2352396421004199-main.pdf

21. COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout

Vaccine, 2 September 2021, Volume 39, Issue 40, Pages 5762-5768

Mazin Barry, Mohamad-Hani Temsah, Jaffar A. Al-Tawfiq

https://www.sciencedirect.com/science/article/pii/S0264410X21011312/pdfft?md5=aee699e7f84711441f67411a53b3eb96&pid=1-s2.0-S0264410X21011312-main.pdf

22. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

Cell Reports Medicine, 28 September 2021, Volume 2, Issue 10, Article 100420

Ami Patel, Jewell N. Walters, Kate E. Broderick

https://www.sciencedirect.com/science/article/pii/S2666379121002822/pdfft?md5=257346af268e8269440ba519cfe9f7b1&pid=1-s2.0-S2666379121002822-main.pdf

23. COVID-19 vaccine hesitancy and reasons for or against adherence among dentists

The Journal of the American Dental Association, 6 May 2021, Volume 152, Issue 9, )Pages 740-746

Michael Belingheri, Massimo Roncalli, Carlo Maria Teruzzi

https://www.sciencedirect.com/science/article/abs/pii/S0002817721002774

24. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines

Journal of Allergy and Clinical Immunology, 20 April 2021, Volume 147, Issue 6, Pages 2075-2082.e2

Kimberly A. Risma, Kathryn M. Edwards, Joshua D. Milner

https://www.sciencedirect.com/science/article/pii/S0091674921005650/pdfft?md5=601e8a2065508b3ab7aecbba736c4df7&pid=1-s2.0-S0091674921005650-main.pdf

25. PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

Heliyon, 4 October 2021, Volume 7, Issue 10, Article e08124

Saumyabrata Mazumder, Ruchir Rastogi, Prabuddha Kumar Kundu

https://www.sciencedirect.com/science/article/pii/S2405844021022271/pdfft?md5=bc597810e15aff3b8265f2d09986306f&pid=1-s2.0-S2405844021022271-main.pdf

26. Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review

Vaccine, 13 August 2021, Volume 39, Issue 40, Pages 5891-5908

Agustín Ciapponi, Ariel Bardach, Pierre M. Buekens

https://www.sciencedirect.com/science/article/pii/S0264410X21010677/pdfft?md5=c63b22221a85557d1372bf1d0bdc72d8&pid=1-s2.0-S0264410X21010677-main.pdf

27. Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

Clinical Microbiology and Infection, 7 June 2021, Volume 27, Issue 10, Pages 1516.e7-1516.e14

David W. Eyre, Sheila F. Lumley, Katie Jeffery

https://www.sciencedirect.com/science/article/pii/S1198743X21002895/pdfft?md5=c3a17abe1b5f4762a288bf903d32098a&pid=1-s2.0-S1198743X21002895-main.pdf

28. The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data

EBioMedicine, 17 September 2021, Volume 72, Article 103574

Aharona Glatman-Freedman, Michal Bromberg, Lital Keinan-Boker

https://www.sciencedirect.com/science/article/pii/S2352396421003674/pdfft?md5=7d00b48ca2c1ab6b4a28ec545cf15458&pid=1-s2.0-S2352396421003674-main.pdf

29. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Vaccine, 5 October 2021, Volume 39, Issue 45, Pages 6601-6613

David G. Alleva, Andrea R. DelperoTodd C. Zion

https://www.sciencedirect.com/science/article/pii/S0264410X21012949/pdfft?md5=617892ab49588d75f5e6e82a5bcb8e5c&pid=1-s2.0-S0264410X21012949-main.pdf

30. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants

Immunity, 17 August 2021, Volume 54, Issue 9, Pages 2159-2166.e6

Aaron J. Schmitz, Jackson S. Turner, Ali H. Ellebedy

https://www.sciencedirect.com/science/article/pii/S1074761321003459/pdfft?md5=5e9a684ecd9d6d1b67f956d8ec84a719&pid=1-s2.0-S1074761321003459-main.pdf

31. Variances in BCG protection against COVID-19 mortality: A global assessment

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 6 June 2021, Volume 24, rticle 100249

Zouina Sarfraz, Azza SarfrazIvan Cherrez-Ojeda

https://www.sciencedirect.com/science/article/pii/S2405579421000383/pdfft?md5=a471c4fe844eb8012e5158fe65c16ac9&pid=1-s2.0-S2405579421000383-main.pdf

32. BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

The Journal of Heart and Lung Transplantation, 21 April 2021, Volume 40, Issue 8, Pages 759-762

Yael Peled, Eilon Ram, Galia Rahav

https://www.sciencedirect.com/science/article/abs/pii/S1053249821022749

WILEY:

1. Risk factors for myocardial injury at admission of 325 patients with coronavirus disease 2019 in Shanghai, China

Xue Mei, Yuanyuan Ji, Zhiping Qian, Yun Ling, Hui Zhu, Xingcheng Zhao, Fang Shen, Qingnian Xu, Zhengguo Zhang, Xingxia Cheng, Yu Liu, Hongying Guo, Ying Zou, Jiefei Wang, Yuyi Zhang, Lie Xu, Hongzhou Lu

Australasian Journal on Ageing

First published: 20 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajag.13003

2. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series

Leon D. Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, Berit Jordan, Jan Purrucker, Carmen Haubner, Corinna Seliger, Hanns-Martin Lorenz, Simon Nagel, Brigitte Wildemann, Martin Bendszus, Wolfgang Wick, Silvia Schönenberger

European Journal of Neurology